Similar articles

• Human papillomavirus typing in HIV-positive women.

  Hameed M, Fernandes H, Skurnick J, Moore D, Kloser P, Heller D. Hameed M, et al. Infect Dis Obstet Gynecol. 2001;9(2):89-93. doi: 10.1155/S1064744901000163. Infect Dis Obstet Gynecol. 2001. PMID: 11495559 Free PMC article. Clinical Trial.
• Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal papanicolaou smears: a study of a university-based inner city population.

  Khanna N, Brooks SE, Chen TT, Simsir A, Gordon NJ, Taylor G. Khanna N, et al. J Hum Virol. 2001 Sep-Oct;4(5):283-7. J Hum Virol. 2001. PMID: 11907386
• Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.

  Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K; DIANAIDS Collaborative Study Group. Branca M, et al. Int J STD AIDS. 2003 Jun;14(6):417-25. doi: 10.1258/095646203765371321. Int J STD AIDS. 2003. PMID: 12816671
• The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.

  Heard I, Palefsky JM, Kazatchkine MD. Heard I, et al. Antivir Ther. 2004 Feb;9(1):13-22. Antivir Ther. 2004. PMID: 15040532 Review.
• Primary screening for human papillomavirus infection.

  Dillner J. Dillner J. Best Pract Res Clin Obstet Gynaecol. 2001 Oct;15(5):743-57. doi: 10.1053/beog.2001.0217. Best Pract Res Clin Obstet Gynaecol. 2001. PMID: 11563870 Review.